Clinical Trials
11 trialsNCT05860335 2024-02-20
Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer
Chinese PLA General Hospital
Phase 2 Unknown
NCT04156698 2023-08-09
Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University
Phase 2 Unknown
NCT05420597 2022-06-15
Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma
Fudan University
Phase 2 Unknown
NCT04995120 2022-01-18
INSIGHT
Fudan University
Phase 2 Unknown
NCT04539600 2021-08-19
Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT03558035 2021-01-29
New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT04624308 2020-11-10
Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC
Peking University
Phase 2 Unknown
NCT04296747 2020-03-05
Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT00637637 2013-08-12
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01516996 2012-03-20
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
The Second People's Hospital of Sichuan
Phase 2 Unknown
NCT00003327 2008-07-24
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Unknown